Friday 6 November 2026 Export TXG’s income statement to Excel — free account

10x Genomics

TXG Healthcare Medical Devices

10x Genomics' revenue for fiscal 2025 (year ended December 2025) was $642.8 million, up 5.25% from fiscal 2024.

Revenue: +1.12%
EPS: +31.8%
Free cash flow: −4.61%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

59.18 1.12 +1.93%

Follow TXG

Alert me

Market cap: $7.6B
P/E: 0.0×
Fwd P/E: −95.9×
Dividend yield: —
F-score: 6/9
Altman Z: 3.99
Beneish M: −3.23
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26 From the 10-Q filed 6 Nov	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	19.11	8.08	4.26	3.17
P/FCF ratio Full definition →	127.41	41.38	22.48	15.76
P/Operating CF Full definition →	746.52	293.60	104.27	49.90
P/B ratio Full definition →	14.10	6.04	3.34	2.56
Price to Tangible BV Full definition →	15.30	6.58	3.63	2.79
EV/Sales Full definition →	18.23	7.23	3.47	2.40
EV/EBITDA Full definition →	0.00	0.00	314.06	0.00
EV/Operating CF Full definition →	113.07	35.10	17.32	11.33
EV/FCF Full definition →	121.52	37.04	18.27	11.93
Quick Ratio Full definition →	4.10	5.09	5.25	3.95
Current Ratio Full definition →	5.12	5.69	5.90	4.46
Net Debt/EBITDA Full definition →	0.00	93.22	76.15	63.41
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.59	0.61	0.67	0.66
Operating CF/Net income Full definition →	(0.82)	(0.95)	(1.94)	(2.51)
Capex/Depreciation Full definition →	0.00	(0.12)	(0.16)	(0.16)
Research and Development Expense of Revenue Full definition →	35.13%	37.60%	37.69%	33.71%
Selling, General and Administrative Expense of Revenue Full definition →	50.48%	52.08%	44.00%	46.15%
Intangible Assets out of Total Assets Full definition →	0.06	0.07	0.06	0.06
Share Based Compensation of Revenue Full definition →	15.33%	16.96%	15.01%	15.19%
Graham Net Nets Full definition →	0.04	0.09	0.17	0.22
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(0.58%)	(1.54%)	(0.80%)	(2.15%)
Free Cash Flow Yield Full definition →	0.78%	2.42%	4.45%	6.35%
Revenue per Share Full definition →	1.15	1.16	1.18	1.33
Operating CF per Share Full definition →	0.12	0.13	0.20	0.33
Capex per Share Full definition →	(0.01)	(0.01)	(0.01)	(0.01)
Free Cash Flow per Share Full definition →	0.11	0.12	0.19	0.31
Cash per Share Full definition →	4.40	4.25	4.21	4.20
Shareholders Equity per Share Full definition →	6.41	6.35	6.35	6.38
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	6.41	6.35	6.35	6.38
Free Cash Flow Full definition →	14.86	15.39	24.52	39.00
Working Capital Full definition →	578.26	556.16	556.14	531.00
Capital Expenditures Full definition →	(0.97)	(1.59)	(1.60)	(1.78)
Net Current Asset Value Full definition →	493.54	470.15	468.30	439.41
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.01	0.01	0.01	0.01
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	—	84.85	54.34	85.48
Average Payables Full definition →	19.83	18.32	13.75	12.82
Average Inventory Full definition →	63.29	60.79	64.10	69.72
Average Assets Full definition →	1,045.25	1,005.02	959.58	980.00
Average Common Equity Full definition →	811.58	799.41	760.61	753.23

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly